Home›Clinical trials›District of Columbia

GLP-1 clinical trials in District of Columbia: 1 recruiting now

One site in one District of Columbia city. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (1)

Weight-loss study of semaglutide

Where: Washington D.C.

What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.

Free to join

Who can join: Adults 18+ who are overweight.

Study record on ClinicalTrials.gov

Med Home Development Grp, Washington D.C.

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Clinical trials by state

Every state with a GLP-1 study recruiting today. 48 of them.

Written and edited by GLP ChartAbout this siteContact
Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.